Metformin imitates biological benefits of exercise in men with prostate cancer

A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome through a biological process closely associated with exercise.An evaluation of serum samples from more than 30 patients with prostate cancer found those who took metformin had elevated levels of the metabolite N-lactoyl-phenylalanine (Lac-Phe), which is known to increase with